DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Niaspan (Niacin Extended-Release) - Current Clinical Trials

 
 



Niaspan Related Clinical Trials

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)(COMPLETED) [Completed]

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites [Completed]

Niacin, N-3 Fatty Acids and Insulin Resistance [Active, not recruiting]

Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Recruiting]

Flexible Doses of Niacin (Niaspan) as an Adjunct to Antipsychotic Medication in the Treatment of First Episode Psychosis [Recruiting]

Randomized, Controlled Trial of Extended-Release Niacin (Niaspan´┐Ż) to Augment Subacute Ischemic Stroke Recovery [Recruiting]

Biosynthesis of PGD2 in Vivo [Recruiting]

The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study [Recruiting]

Effect of Niacin in the Lipoprotein (a) Concentration [Not yet recruiting]

Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid [Recruiting]

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia [Completed]

Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function [Active, not recruiting]

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis [Recruiting]

A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) [Recruiting]

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Recruiting]

Niacin/Laropiprant and Endothelial Function [Not yet recruiting]

Niacin and Endothelial Function in Early CKD [Recruiting]

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL [Completed]

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease [Recruiting]

MK0524A Clinical Efficacy Study [Completed]

Niaspan in Diabetic Nephropathy [Recruiting]

Extended Niacin/Laropiprant in Patients With Type 2 Diabetes [Active, not recruiting]

Niacin to Improve Blood Flow in People With Sickle Cell Disease [Recruiting]

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol [Active, not recruiting]

Study of Extended Release Niacin/Laropiprant on Lipids [Active, not recruiting]

Effect of Niaspan on Cholesterol in Men [Recruiting]

Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects [Recruiting]

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis [Recruiting]

Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study) [Recruiting]

Study of the Effectiveness and Safety of Niaspan « in the Treatment of Lipid Abnormalities in Latin America [Recruiting]

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate [Recruiting]

A Placebo-Controlled Prospective Study to Evaluate Flushing in Subjects Administered Niaspan« Plus Aspirin for Six Weeks [Recruiting]

Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome [Not yet recruiting]

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction [Recruiting]

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Recruiting]

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease [Recruiting]

Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression [Not yet recruiting]

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study) [Recruiting]

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133) [Recruiting]

The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients [Recruiting]

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients [Completed]

Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication [Completed]

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC [Completed]

Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse [Recruiting]

The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker [Not yet recruiting]

Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study) [Recruiting]

Role of Prostaglandins on Niacin-Induced Flushing [Recruiting]

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia [Completed]

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) [Recruiting]

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions [Recruiting]

Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan«-Induced Flushing in Subjects With Dyslipidemia [Recruiting]

Effect of an Investigational Compound on Tolerability of Extended Release Niacin [Completed]

Merck Carotid Atherosclerosis Trial [Recruiting]

Tolerability of MK0524A Versus Niacin Extended-Release [Completed]

Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL [Recruiting]

Effect of MK0524A on Flushing Caused by Niacin [Completed]

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) [Completed]

Extended Release (ER) Niacin/Laropiprant Add on Study [Not yet recruiting]

Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) [Recruiting]

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers [Recruiting]

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Completed]

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST [Completed]

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study) [Completed]

Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy [Completed]

MK0524A Phase IIb Study [Completed]

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers [Recruiting]

Exercise Versus Extended-Release Niacin in Patients With Coronary Heart Disease and Low High-Density Lipoproteins (HDL) Cholesterol: Effect on Lipid Profile and Endothelial Function [Recruiting]

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119 AM2) [Recruiting]

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions [Recruiting]

Study to Test GSK256073 in Patients With Dyslipidemia [Recruiting]

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [Recruiting]

Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD) [Recruiting]

High-Density Lipoprotein (HDL) Treatment Study [Completed]

Safety Study of Nicotinamide to Treat Alzheimer's Disease [Recruiting]

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) [Completed]

Endpoint Validation Study [Completed]

Alternative Options to Minimize Niacin-Induced Flushing [Recruiting]

The Low HDL On Six Weeks Statin Therapy (LOW) Study [Active, not recruiting]

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis [Recruiting]

Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE [Recruiting]

High-Density Lipoprotein (HDL) Modulation and Endothelial Function [Recruiting]

Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

The Topical Niacin Skin Flush Test in First Episode Psychosis [Recruiting]

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities [Recruiting]

Combined Effects of Non-Statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study [Recruiting]

Obesity and Nonalcoholic Fatty Liver Disease [Recruiting]

Carotid IMT (Intima Media Thickening) Study

Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children [Recruiting]

Gulf War Illness: Evaluation of an Innovative Detoxification Program [Not yet recruiting]

Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia [Completed]

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Completed]

Coronary Drug Project Mortality Surveillance [Completed]

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-Lowering Agents [Completed]

Cholesterol-Lowering Atherosclerosis Study (CLAS) [Completed]

Coronary Drug Project [Completed]

An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia [Active, not recruiting]

Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow [Not yet recruiting]

Effects of Micronutrient (Chromium) Supplementation on Diabetes [Recruiting]

Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia [Completed]

Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Patients With Mixed Hyperlipidemia and Two or More Risk Factors to Cardiovascular Disease. [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012